ArticlePloS one2013

Prognostic significance of ESR1 amplification and ESR1 PvuII, CYP2C19*2, UGT2B15*2 polymorphisms in breast cancer patients.

Aleksandra Markiewicz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.